MPI RESEARCH ACQUIRES
THE JASPER CLINIC
Clinical Phase I–IIa Capability
MPI Research is renowned in early-stage development for deep scientifi c
expertise and state-of-the-art technology at the world's largest preclinical
research facility. With our acquisition of The Jasper Clinic — a 50-bed
clinical trial unit with a long track record in fi rst-in-human studies — we have
taken a further signifi cant step towards being the leading integrated resource
for early development. We now offer you the full continuum of lead to
proof-of-concept services for new drug candidates.
For more information, visit www.mpiresearch.com
Taking You Further.